Trial intelligence / Profile preview

ColoViD: Vitamin D and microbiota in colorectal cancer

2015-000467-14Phase 2Terminated

Sponsor
European Institute of Oncology
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in colorectal cancer (CRC) and colon adenocarcinoma comparing Vitamin D (DIBASE) with Placebo (2 arms). Started Dec 2020; status: terminated.

02

Drugs

cholecalciferol
03

Conditions

colorectal cancer (CRC)colon adenocarcinoma

Beyond the preview

Go deeper on 2015-000467-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000467-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call